BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, March 29, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Oct. 14, 2008
View Archived Issues
Novel anticoagulants disclosed in recent Novo Nordisk patent
Read More
New treatment options for AD and other cognition disorders described in recent Roche patent
Read More
New clinical data on pazopanib presented
Read More
MDRNA selects MDR-04227 as lead candidate in hypercholesterolemia program
Read More
Recent Plexxikon and Janssen patents impart novel antiobesity drugs
Read More
Kamada presents positive phase II data for inhaled AAT in cystic fibrosis
Read More
Biodel to meet with FDA by end of January 2009 to discuss NDA for diabetes drug VIAject
Read More
Natural extract derivative found as novel PDE5A1 inhibitor with better selectivity than sildenafil
Read More
BioWa and CSL sign license agreement for Potelligent technology in ADCC-enhanced antibodies
Read More
AZD-1152-HQPA enhances oxaliplatin effects in colorectal tumor model
Read More
Pfizer presents data on asthma candidate Compound X
Read More
HE-3235 inhibits tumor growth in castration-resistant prostate cancer model
Read More
Ablynx presents update on development of Nanobodies antibody-derived therapeutic proteins
Read More
Glenmark initiates phase II study of PDE4 inhibitor oglemilast in asthma
Read More
OncoGenex achieves regulatory milestone for lead product candidate, OGX-011
Read More
Ostarine meets primary endpoint in phase II cancer cachexia trial
Read More
Avontec reports results of phase IIa AVT-02 trial in psoriasis
Read More
FDA agrees with Neurobiological to consolidate Viprinex phase III trials
Read More
R&D highlights from the UBS Global Life Sciences Conference in New York: Vical Incorporated
Read More
Revotar presents phase I data for bimosiamose 5% cream in psoriasis
Read More
Sweden grants approval to Cyto Pulse to initiate phase I/II trial of a xenogenic DNA vaccine
Read More
Genmab reaches milestone following initiation of treatment in phase I study of ofatumumab
Read More
FDA grants marketing approval to Boston Scientific's Taxus Liberte paclitaxel-eluting stent
Read More
Migenix presents update on development of Omigard for catheter-related infections
Read More